AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%
Market Cap$460.2B
LTM Gross margin
81.1%
5Y avg
76.6%
Drug Manufacturers - General industry median
69.6%
Stock quality & Intrinsic value
7/10
(0.6%) overvalued

AstraZeneca PLC Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
AZN
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross margin
75.8%
77.6%
79.0%
79.7%
79.1%
82.4%
80.8%
82.1%
80.7%
79.5%
77.6%
81.2%
82.1%
80.8%
77.7%
79.8%
80.1%
66.8%
72.1%
82.4%
AZN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AZN and see if it's the right time to invest.
Dive in

AstraZeneca PLC (AZN) Gross margin comparison analysis

Crunching data... Almost there!

AZN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AstraZeneca PLC's Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 81.1%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Gross margin for AstraZeneca PLC have been 75.3% over the past three years, and 80.4% over the past five years.

2) Is AstraZeneca PLC's Gross margin Good?

As of today, AstraZeneca PLC's Gross margin is 81.1%, which is higher than industry median of 69.6%. It indicates that AstraZeneca PLC's Gross margin is Good.

3) How does AstraZeneca PLC's Gross margin compare to its peers?

As of today, AstraZeneca PLC's Gross margin is 81.1%, which is higher than peer median of 69.6%. The list of peers includes LLY, MRK, NVS, ABBV, SNY, JNJ, BMY, PFE, AMGN, GILD.